The Thai government has provided about 2.8 billion baht in funding to nine state and private agencies for their research, development and production of anti-viral vaccines, with the aim of turning Thailand into the regional hub of vaccine production.
Government spokesman Anucha Burapachaisri said today (Saturday) that Prime Minister Prayut Chan-o-cha attached importance to supporting the capability of Thailand, in the research and development of COVID-19 vaccines, by setting aside an initial fund of 1.8 billion baht last December.
He said that the government has now set aside an additional 995 million baht for the National Vaccine Institute, to be distributed to three agencies, to make preparations for technology transfer in the production of COVID-19.
The first 1.8 billion baht was divided as follows:
Additionally, the Government Pharmaceutical Organization-Merieuk Biological Products Company is to increase their vaccine production capacity to an industrial level, to handle domestic production of vaccines.
The second amount of 995 million baht is split between:
Anucha said that the funding for Siam Bioscience will be returned to the government in the form of vaccines, equivalent to the amount of funding it receives from the taxpayer.